Introduction
The emergence of resistant microbes to classical antibiotics has prompted the study and development of alternative agents as a new generation of antimicrobial compounds. Alternatives to classical antibiotics are in need and peptide antibiotics such as antimicrobial peptides (AMPs) have shown significant promise as potential candidates for future therapeutics. The advantages of AMPs over conventional antibiotics include, but are not limited to, a broader spectrum of activity, nonreceptor mediated modes of action, and minimal induction of drug resistance. AMPs were initially isolated more than two decades ago from various organisms, including insects, hemolymphs, frogs and mammalian neutrophil granules [1] [2] [3] [4] . They are essential and evolutionarily conserved elements of the innate defense system of these organisms. AMPs generally consist of 12-50 aa that are mixed between hydrophobic and hydrophilic groups, allowing for solubility in both aqueous and lipid phases. They have a net positive charge of 2-9 and most of them adopt amphipathic structures when bound on the membrane. In the past decade much focus has been centered on modification of AMPs to improve their antimicrobial activity, increase their in vivo efficacy and retention, and lower the cost of their manufacture [5, 6] . Generally, modifying the peptides by changing the amino acid sequence or by alternating their order within the sequence has been shown to increase antimicrobial activity [3, 7, 8] . However, other peptide modifications are interesting as well. Linking peptides with other biological macromolecules such as sugars or lipids has proven to yield higher antimicrobial activity compared to the parent non-linked peptides [8, 9] .
Natural lipopeptides (LiPs) are produced nonribosomally in bacteria and fungi during cultivation in various carbon sources. The structure consists of a hydrophobic lipid moiety covalently attached to hydrophilic peptides of 6-7 amino acids. Some of them are highly active against antibiotic-resistant pathogenic bacteria. For instance, polymyxin B, one of the most studied lipopeptides, has been long used to treat topical and urinary tract infection [10] and daptomycin has been approved by the Food and Drug Administration for topical infections [11] . Although much attention has been focused on naturally occurring LiPs, most of these native LiPs are non-cell-selective and can cause severe cytotoxicity for mammalian cells. Synthetic LiPs have attracted considerable interest as the alternative to classical AMPs and native LiPs due to their non-cytotoxic activity, high efficacy and retention in vivo, and lower cost of manufacture [12] . Synthetic LiPs consist of a short linear or cyclic peptide sequence with a positive net charge and a fatty acid chain (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) carbon chain length) attached at the N-terminus through a covalent bond [8, 9] . Addition of the carbon chain onto the short AMP has been proven to yield more than a 100-fold increase in antimicrobial activity for some LiPs and reduced the cytotoxicity towards mammalian cells compared to the parent peptides or other associated antibacterial/antifungal compounds. Some examples of this are C 12 -OOWW-NH 2 , C 14 -OOWW-NH 2 , C 12 -KLLK-NH 2 and C 16 -KGGK-NH 2 , where O is ornithine amino acid [7] [8] [9] . Among the synthetic LiPs reported, the shortest LiP was composed of 2-4 amino acids linked to a fatty acid (12-16 carbon chain) [9, 13] . The fatty acid tail has been shown to compensate for the hydrophobicity seen in the classical AMPs and a length of 2-4 amino acids has been shown to be sufficient for bactericidal potency of these LiPs [9, [13] [14] [15] .
The mode of action of LiPs is believed to be similar to that of conventional AMPs, where the antimicrobial activity is governed by the optimal hydrophobicity of the peptide and its ability to form a specific conformation with amphipathic structure upon membrane binding [16] . LiPs remain in a soluble oligomeric form in solution, and bind to the cell surface via electrostatic interactions. LiPs accumulate on the cell surface until reaching a specific concentration called the lipid phase partitioning threshold. At concentrations above this threshold, LiPs can traverse through polysaccharides barriers via the microorganism's selfpromoted uptake mechanism to reach the outer and inner membrane of Gram negative bacterial cells, and the cytoplasmic membrane of Gram positive bacterial cells [16, 17] . The inner/cytoplasmic membrane is the major target of LiPs where permeabilization and depolarization take place, leading to membrane disintegration and eventually cell death [8] . Despite extensive investigation on the effect of acyl chain length and peptide composition of LiPs on bactericidal potency, much less attention has been given to the mechanism of action. As a consequence, the optimization of LiPs for better activity could lack the fundamental or concrete understanding of how acyl chain length can affect the activity and could hamper the possibility of designing LiPs with high therapeutic potency.
KYR, one of the shortest AMPs reported by far, is the amino acid sequence (balpha N 139-141) of the bovine hemoglobin alpha chain strand. It was part of the longer amino acid sequence (b alpha N 137-141) 137-141) that was obtained from hydrolyzing the hemoglobin alpha chain. Based on the sequence (b alpha N 137-141), KYR was the shortest synthesized sequence with a minimum inhibitory concentration (MIC) in the range of 1-4 μM [1] . With such high activity, we expected that modifying KYR through amidation (−NH 2 ) of the C-terminus and acylation of the N-terminus with a lipid functional group might yield better antimicrobial activity. We were also interested in elucidating the mechanism of the effects of the acyl chain length on the antimicrobial activity in detail. In this study, we investigated the antimicrobial activity and mode of action of KYR-NH 2 and its lipid modified forms with decanoic acid (C 10 ), lauric acid (C 12 ), myristic acid (C 14 ), or palmitic acid (C 16 ) attached at the N-terminus against 4 strains of pathogenic bacteria, including the multidrug resistant Klebsiella pneumonia. The time-course killing activity as a function of the acyl chain length of the LiPs was determined. The geometric mean of MIC and the selectivity index was shown. The structure and aggregation tendency of the LiPs were determined using circular dichroism and dynamic light scattering, respectively. The membrane disruptive action of the LiPs was observed using fluorescent probes in order to monitor outer/inner membrane permeabilization and membrane depolarization in a timely manner. Cell morphology after treatment with the LiPs was observed by atomic force microscopy. From these results, a step by step model of LiPs action was determined.
Materials and methods

Materials and cell culture
LiPs were synthesized by Fmoc solid-phase method at GL Biochem (Shanghai) Ltd. (Shanghai, China). N-phenyl-1-naphthylamine (NPN) was purchased from Bio-Rad (Hercules, CA). Polymyxin B was purchased from Sigma-Aldrich (St. Louis, MO). Luria-Bertani broth (LB) and nutrient agar (NA) were purchased from HiMedia (Mumbai, India). The LIVE/ DEAD Light™ bacterial-viability kit was purchased from Invitrogen® (Grand Island, NY). Bis-(1,3-Dibutylbarbituric Acid)Trimethine Oxonol (DiBAC 4 (3)) was purchased from Molecular Probe®, Inc. (Grand Island, NY). Pathogenic microorganisms were kind gifts from the Thammasirirak Laboratory, Protein and Proteomics Research group, Khon Kaen University. The following strains were used in this study: Staphylococcus aureus ATCC 25923, Staphylococcus epidermidis ATCC 12228, Escherichia coli MG 1655 ATCC 700926, E. coli O157:H7 ATCC 43895, and K. pneumonia ATCC 17736. All microbial strains were stored at −70°C in 20% glycerol in an Eppendorf tube. The bacteria were streaked on NA and then cultured at 37°C overnight. Colonies were picked and cultured in LB broth (10 g of tryptone, 5 g of yeast extract, and 10 g of NaCl per liter) at 37°C in an incubator overnight and then subcultured at 37°C in a 200 rpm shaker-incubator for 2-3 h to yield a mid-logarithmic growth phase culture.
Peptide design and synthesis
LiPs were synthesized by Fmoc solid-phase method at GL Biochem (Shanghai) Ltd. (Shanghai, China). The lipophilic acid was attached to the N terminus of a resin-bound peptide by standard Fmoc chemistry, followed by peptide cleavage from the resin and purification by reversed-phase high-performance liquid chromatography (RP-HPLC; N98%). The LiP compositions were confirmed by electrospray ionization mass spectroscopy (ESI-MS) and amino acid analysis. LiPs were dissolved in 10% DMSO at a concentration of 1 mg/mL and the peptide solutions were stored at − 20°C before subsequent antibacterial and structural assessments.
CD analysis
All spectra were collected on a Jasco J-815 CD spectrophotometer (JASCO, Easton, MD) using a circular quartz cuvette with a path length of 1.0 mm from 198 nm to 260 nm at room temperature. To investigate the conformational changes induced by a secondary structure promoting agent, the powder LiPs were dissolved in 5% TFA to make a stock of 256 μM. The stock was diluted to 20 μM in 10 mM sodium phosphate buffer, pH 7.4 or 50% trifluoroethanol (TFE) when used. Baseline spectra for each solvent were obtained prior to the peptide spectra. The CD spectra were recorded with a 0.5 nm bandwidth and a scan speed of 50 nm/min for 10 repeats. CD data are expressed as the mean residue ellipticity in deg·cm 2 ·dmol −1 . The content of the secondary structure was analyzed with CONTIN LL program [18] .
Analysis of tendency of aggregation
Dynamic light scattering (DLS) was performed to characterize the sizes of the peptide aggregates in solution using the Zetasizer Nano ZS (Malvern), Research Instrument Center Khon Kaen University. Following pervious method [18, 19] , the 256 μM stock of LiPs in 5% TFA was diluted to a series of concentration in 10 mM sodium phosphate buffer, pH 7.4. Each sample of 1.5 mL was transferred to a square cuvette for DLS measurement. Data were collected and presented as the mean of three repeats.
The morphology of the peptide/LiPs was imaged by atomic force microscope (AFM) according to previously described methods [18, 19] . Briefly, each concentration of peptide/LiPs (20, 40, 80, 128, and 256 μM) was dissolved in 10 mM sodium phosphate buffer, pH 7.4. The peptide or LiP solution was placed on a glass slide and dried at room temperature. Then, the morphology of the peptide/LiPs was imaged in tapping mode by atomic force microscope (XE-120 Park Systems), Research Instrument Center, Khon Kaen University. Applied Si probes were used for cantilevers and a resonance frequency of 200-500 kHz. All height images were collected.
Minimum inhibitory concentration (MIC) measurements
The MICs of the peptides and drugs against five bacterial strains were determined by the broth microdilution method as described previously [8, 20, 21] . Briefly, a range of concentrations (1.25, 2.5, 5, 10, 20, 40, 80 and 160 μM) of the LiPs was prepared by serial dilution and added to an equal volume of bacterial solution (100 μL) in each well of a 96-well plate. The plates were incubated at 37°C and read after 18 h. The MIC was defined as the concentration at which no microbial growth was observed visually or spectrophotometrically via readings of optical density (OD) at 600 nm (microplate reader model 680, BioRad, USA). Growth media containing only microbial cells was used as the negative control. Each MIC test was carried out in triplicate.
Bacteria viability measurement
Time-kill experiments against three Gram-negative bacterial strains and two Gram-positive bacterial strains using methods described previously [22, 23] and viability were measured with a LIVE/DEAD BacLight™ bacterial-viability kit (Invitrogen) using the protocol recommended by the manufacturer. Briefly, mid-log-phase cultures of these strains were first adjusted to the same cell density at OD 655 . The cells were harvested and washed three times in potassium phosphate buffer (PPB). The killing was initiated by adding an aliquot of cell suspension (1 × 10 7 CFU/mL) to 75 μL/well of PPB containing different concentrations of LiPs (1.25, 2.5, 5, 10, 20, 40, 80 and 160 μM) and 75 μL/well of 2× dye kits solution was added to a 96-well plate. Samples were incubated at 37°C in the dark for 90 min and fluorescence was measured every 10 min for 90 min, while samples without the peptide were used as controls. The excitation and emission wavelengths were 485 nm and 530 nm for green fluorescence (em1) and 603 nm for red fluorescence (em2), respectively. The ratio of live cells comparing to dead cells was calculated as follows:
, where F cell, em1 is the integrated intensity of the portion of green fluorescence and F cell, em2 is the integrated intensity of the portion of red fluorescence. Percentage of dead cells was calculated as follows: (1 − Ratio G/R ) * 100
Eukaryotic cell toxicity testing
Hemolytic activity of peptide/lipopeptide was assayed spectrophotometrically for their ability to induce hemolytic according to the Catiau, L et al. [1] . Briefly, human red blood cells (hRBCs) were isolated via centrifugation, washed three times with PBS, and then suspended to 4% (v/v) in PBS. 100 mL hRBC suspensions were added into each well of a sterilized 96-well plate. To each well was added 100 □L peptide solution, and the plates were incubated for 1 h at 37°C and centrifuged at 1000 g for 5 min. 100 □L aliquots of supernatant were transferred to fresh 96-well plates and hemoglobin release was monitored with a SpectraMax M5 fluorescence microplate reader by measuring the absorbance at 405 nm. 0% and 100% hemolysis was determined in PBS and 0.1% Triton X-100, respectively.
A cell viability assay (MTT assay) is one of the most widely used methods for toxicity analysis [24] . Briefly, Vero cells (kidney epithelial cells) were seeded at 5 × 10 3 cells per well and incubated in RPMI with or without the tested LiPs for 24 h at 37°C, 5% CO 2 . After exposure the test medium was discarded, and the cells were incubated with 100 μl of MTT solution (0.5 mg/ml MTT diluted in DMSO) for 4 h at 37°C, 5% CO 2 . Subsequently, the MTT solution was discarded and 100 μl of DMSO was added to each well. Optical density (OD) was read on a microplate reader at 570 nm, with a reference at 655 nm. Cell viability for each treatment was calculated as the ratio of the mean OD of replicated wells relative to that of the control (only cell culture medium added) [9, 25, 26] .
NPN outer membrane permeabilization assay
The outer membrane permeabilization activity of the ultrashort peptide/lipopeptide was determined by the NPN uptake assay of Loh et al. [27, 28] . Briefly, an overnight culture of bacteria was diluted in LB medium and grown to an OD 655~0 .5. The cells were harvested, washed, and resuspended in the same volume of buffer (5 mM HEPES, pH 7.2, 5 mM KCN). For the NPN assay, 1 mL of cells and 0.02 mM N-phenyl-1-naphthylamine (NPN) were mixed, and the initial fluorescence was measured using a SpectraMax M5 fluorescence microplate reader. The excitation and emission wavelengths were 350 nm and 429 nm, respectively. Peptide/lipopeptide was added to the mixture to a final concentration of 20 μM. Increases in fluorescence due to partitioning of NPN into the outer membrane was recorded over time until no further increase in intensity was observed. Fluorescence increase was reported as a percentage of the fluorescence measured after Triton-X 100 treatment. The fluorescence blank was NPN with bacteria only.
Inner membrane permeabilization assay
To assess the ability of SYTOX® Green to alter the permeability of the inner membrane, experiment was performed according to Li et al. with some modifications [29] . Briefly, bacteria cells were grown to mid logarithmic phase at 37°C, washed three times and suspended in PBS buffer (1 × 10 7 cells/mL) containing 10% LB medium. Aliquots of 90 μL of this cell suspension were deposited in each well of a standard 96-well plate. Then, 10 μL of the 20 μM final concentration peptide containing 5 μM SYTOX® Green was added to the wells. The time-dependent increase in fluorescence excited by binding of the cationic dye to intracellular DNA was monitored using a SpectraMax M5 fluorescence microplate reader. The excitation and emission wavelengths were 504 nm and 523 nm, respectively.
Membrane depolarization using DiBAC 4 (3)
Bacterial membrane potential was determined by using the lipophilic anionic membrane potential-sensitive dye bis-1,3-(dibutylbarbituric acid)trimethine oxonol DiBAC 4 (3) (Molecular Probes, Inc.) by the method of Mason et al. [30, 31] with some modifications. Briefly, bacterial cells incubated overnight in LB medium were diluted 1:100 with fresh medium and incubated at 37°C to log-phase growth. Cells were harvested to give a density of 1 × 10 7 cells/mL and washed three times and resuspended in 5 mM HEPES buffer. Bacteria were incubated in different concentrations of LiPs (20 and 40 μM final concentrations LiPs) containing DiBAC 4 (3) at a final concentration of 10 mg/mL. The doseresponse assay was monitored using a SpectraMax M5 fluorescence microplate reader after 15 and 30 min of incubation at 37°C. The excitation and emission wavelengths were 493 nm and 516 nm, respectively. The potential membrane activity of the LiPs is expressed as follows:
where F 0 is the stable fluorescence value after addition of the DiBAC 4 (3), F p is the fluorescence value of the LiPs for 15 and 30 min, and F PMB the fluorescence signal of polymyxin B.
Bacterial attachment to glass slides for AFM imaging
Colonies were picked and cultured in LB broth at 37°C in an incubator overnight and then subcultured at 37°C in a 200 rpm shaker- incubator for 4-5 h to yield a mid-logarithmic growth phase culture. The cells were harvested, washed, and resuspended in a 0.85% NaCl solution. A 10 ml vial of bacterial solution (1 × 10 9 cells/mL) was combined with 300 ml of 100 mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (pH 5.5, EDC, Pierce). The vial was agitated for 10 min. Following EDC treatment, 300 ml of 40 mM Nhydroxysulfosuccinimide (pH 7.5, Sulfo-NHS, Pierce) was combined with the bacterial solution for 10 min [32, 33] . Bacterial attachment to glass slides for AFM (MFP-3D-SA, Asylum Research, Santa Barbara, USA) measurements Glass slides were rinsed with ultrapure water (18.2 MΩcm resistivity and b10 ppb total organic carbon, Millipore Milli-Q plus, Billerica, MA, USA), followed by sonication for 15 min. Glass slides were immersed in 30% 3-aminopropyltrimethoxysilane in methanol (Sigma-Aldrich, USA) for 20 min. and rinsed with methanol and ultrapure water. Bacterial solution was added to glass slides and agitated at 70 rpm for 1-2 h to promote bacterial lawn formation.
Results and discussions
Physical properties of the LiPs
LiP design and characterization
The design of LiPs with the positively charged head group and the hydrophobic tail in this study was based on 2 known factors. 1) The specific amino acid sequence for ultrashort peptides (2-4 aa) is required to obtain strong antimicrobial activity. 2) Addition of the fatty acid tails to the ultrashort peptides resulted in increasing bactericidal potency according to the chain length and the net hydrophobicity [8, 9, [34] [35] [36] . Here, we chose the KYR sequence, the minimal sequence from the human hemoglobin alpha chain reported to have potent antimicrobial activity, as a parent ultrashort peptide [1] . We speculated that amidation and addition of acyl tails would increase the activity of KYR. Then later in this study, the activity-acyl chain length relationship was further explored by the time-mannered, membrane-disruptive mode of killing.
The KYR-NH 2 sequence and its lipid modified form were synthesized by the solid-phase peptide synthesis using standard 9-fluorenylmethoxy carbonyl chemistry on Rink amide-4-methylbenzhydrylamine hydrochloride salt resin. Decanoic acid (C 10 ), lauric acid (C 12 ), myristic acid (C 14 ) and palmitic acid (C 16 ) were conjugated to the KYR-NH 2 sequence via modified solid-phase methods. Besides C X -KYR-NH 2 , the uncharged C 14 -YYY was also synthesized to serve as a negative control. The sequence and molecular weight of the peptide and LiPs were verified by EIS-MS. Table 1 summarizes the theoretically calculated and measured molecular weight of each peptide/LiP. All LiPs have measured molecular weight values in agreement with their theoretical values, suggesting that the LiPs were successfully synthesized. The relative hydrophobicity of designed LiPs in aqueous solution indicated that differences in hydrophobicity were reliably reflected by different HPLC retention times. The Fig. 1 . The molecular structures of parental peptide, KYR-NH 2 and LiPs, C 10 , C 12 , C 14 , C 16 -KYR-NH 2 and C 14 -YYY-NH 2 respectively. Color scheme: carbon (heavy gray), hydrogen (light gray), oxygen (red), and nitrogen (blue) using ChemBioDraw Ultra 13.0 program. Fig. 2 . The CD spectra of 20 μM LiPs were measured in 10 mM sodium phosphate buffer, pH 7.4 (A) or in 50% trifluoroethanol (B). amino acid sequences of the parental and modified peptides are listed in Table 1 . The molecular structures of the LiPs series are depicted in Fig. 1 . According to the atomic calculation from ChemBioDraw Ultra 13.0 program, the size of these LiP molecules were 2-3 nm in length. In their unfolded state, the hydrophilic head group occupied the space about half of the whole molecule, with C 16 -KYR-NH 2 containing longest acyl tail.
Analysis of secondary structure by circular dichroism (CD) spectroscopy
Circular dichroism (CD) has been used to study protein or peptide conformational change in different environment, e.g., aqueous solution, structure-promoting solvents, and lipid vesicles. Generally, AMPs is partially folded in aqueous solution, but start adopting more secondary structure with amphipathicity in structure-promoting solvents like trifluoroethanol (TFE), or in the presence of lipid vesicles [37] . In this study, to follow the folding ability of the LiPs in the structurepromoting environment, we performed CD spectroscopy in 50% trifluoroethanol (TFE) in sodium phosphate buffer, pH 7.4. The CD spectra of all the LiPs in buffer indicated a disordered structure, as evidenced by relatively flat molar ellipticity from the baseline (Fig. 2A) . On the other hand, while in 50% TFE, all LiPs, including KYR-NH 2 adopted secondary structure as evidenced by the negative and positive change in molar ellipticity compared to the baseline at around 198 nm and 215 nm, respectively. The analysis of the secondary structure content by CONTIN LL program indicated that in 50% TFE KYR-NH 2 and all LiPs consisted of 51.3% turns and random coils, 31.1% β-sheets, and 11.6% α-helix. Our results demonstrated that there was no secondary structure of KYR-NH 2 and all LiPs in aqueous solution. This indicated that the 3 amino acid long was not enough to allow the structure to be partially folded, and addition of the acyl chain could not promote the secondary structure. On the contrary, around 40% of secondary structure was found in KYR-NH 2 and LiPs in the presence of TFE. This result indicated that KYR-NH 2 and LiPs, no matter how short the peptide sequence was, were able to adopt the secondary structure. The explanation owed to the fact that addition of TFE can withdraw water molecules from LiPs. This may resulted in structural rearrangement of LiPs in either intra-or intermolecular fashion to yield secondary structure. Our study reports the induced-secondary structure of the ultrashort LiPs as consisting of up to 31% β-sheet, while Domalaon, R. et al. [38] reported the prolyprolin II-helix in the ultrashort LiPs they investigated. Most studies have reported the structure of LiPs consisting of the longer chain of amino acids, in which the peptide chains could bend and interact with the fatty acid chain, resulting in an α-helical conformation [39, 40] .
Hydrodynamic diameter and nanostructure of LiPs
Antimicrobial LiPs exist as aggregates in solution in both visible and invisible forms, and once bound to the membrane they dissociate via unknown mechanism and insert into the phospholipid bilayer [16] . In this study, the effect of acyl chain length on oligomerization state of LiPs was determined by DLS and AFM (Fig. 3) . When observed by DLS, the size of LiPs varies from 150 to 500 nm in hydrodynamic diameter at concentrations between 1.25-40 μM. At concentration 80 μM C 14 -KYR-NH 2 and C 16 -KYR-NH 2 exhibited slightly higher aggregates, with hydrodynamic diameter above 1000 nm (Fig. 3A) . The overall results from DLS appear to be quite random to allow us to speculate the trend of particle diameter against the concentration of the solution. Therefore, additional AFM images of the LiPs were taken to provide actual nanoscale resolution topology (Fig. 3B-F , 2*2 μm with inset of 10*10 μM). The AFM image of KYR-NH 2 at 256 μM shows homogeneous topology with an average height of 0-250 pm. The flat topology indicates the absence of visible multimeric states of KYR-NH 2 . C 14 -KYR-NH 2 at 80 μM also exhibited flat height between 0-0.8 nm, but a fibrillar form with a height of 2.5-7.5 nm was found at 256 μM (Fig. 3C-D) . C 16 -KYR-NH 2 exhibited droplet-like morphology with a height of 2-4 nm and rod-shape topology with a height of 40 nm at 80 and 256 μM, respectively (Fig. 3E-F ). Our findings are partially similar of that of C. Chen et al. [41] that these LiPs could self-assemble into nanostructure like the peptide amphiphiles A9K, A12K, and A9K2. Although what found in their study were mainly nanorod shape, C 14 -KYR-NH 2 exhibited long fibrillar, dendrite-like structure with length of 1-5 μm (Fig. 3D) , and C 16 -KYR-NH 2 had worm-like shape with length of 0.5-4 μm. Our result was in agreement with previous studies which showed that LiPs were aggregates in solution under certain concentrations [13, 39, 40] .
Concentration-dependent and time-dependent antimicrobial activity of LiPs
Concentration-dependent antimicrobial activity of the LiP series was determined against a set of Gram-positive and Gram-negative strains including S. aureus 1466, S. epidermidis ATCC 12228, E. coli O157:H7 ATCC 43895 and K. pneumonia ATCC 17736. The activity of LiPs was evaluated by a LIVE/DEAD BacLight™ bacterial-viability kit to determine the bacteria viability as shown in Fig. 4 . At 40 μM, C 12 -KYR-NH 2 and C 14 -KYR-NH 2 had antibacterial activity towards S. aureus 1466, and S. epidermidis ATCC 12228 comparable to that of Gentamicin at 40 μM (Fig. 4A,B) . This indicates that the LiPs had strong activity against the representative Gram positive strains like that of Gentamicin. The activity of these LiPs toward E. coli O157:H7 ATCC 43895 and K. pneumoniae ATCC 17736 was not as strong as polymyxin B (Fig. 4C,D) . C 12 -and C 14 -KYR-NH 2 at 40 μM could induce death of E. coli O157:H7 ATCC 43895 up to 75% and 85%, respectively (Fig. 4C) , and death of K. pneumoniae ATCC 17736 up to 50% (Fig. 4D) . All LiPs except C 16 -KYR-NH 2 displayed antimicrobial activity 2-3 folds higher than KYR-NH 2 . The average MIC for 4 strains tested (the geometric index, GI) indicated that C 14 -KYR-NH 2 was most effective, with GI at 25 μM. C 12 -KYR-NH 2 had GI 40 μM, and KYR-NH 2 , C 14 -KYR-NH 2 and C 16 -KYR-NH 2 had the same GI as 80 μM (Table 1) .
KYR-NH 2 in our study had MIC 20-fold higher than KYR firstly reported [1] . It might be due to the amidation on the C-terminus that reduce the activity. Besides the amidation, the discrepancy of antibacterial activity may result from several factors including the source of peptide synthesis, the method in determining MIC, and the pathogen strains used. Also, one of the limitations in using the ultrashort LiPs is that they tend to bind to proteins non-specifically, which results in more than 4-fold loss of antibacterial activity [36] . Regarding the activity against S. aureus, C 14 -KYR-NH 2 from this study exhibited relatively lower activity (25 μM, Table 1 ) than other ultrashort LiPs reported in previous studies [1] . In those reports, C 16 -KLLK had MIC 3.12 μM [8] , C 16 -KGGK and C 16 -KAAK 8 μM [14] , C 12 -OOWW and C 14 -OOWW 1.95 μg/mL, where O was ornithine and W was tryptophan [9] . and lastly, C 16 -KGK and C20-KGK 8 μg/mL [36] for S. aureus, respectively. The different MIC values may be due to the different strains of S. aureus used in our and their studies, and different techniques in determining the MIC. The presence of metal ions in the culture media may contribute to the loss of activity observed in our LiPs as well [42, 43] .
Next, to determine the kinetics of bacterial killing by LiPs as compared to the positive control antibiotics, the bacterial viability was monitored at 10 min intervals over 90 min with a LIVE/DEAD BacLight™ bacterial-viability kit (Fig. 5) . The results show that at 40 μM, C 12 -and C 14 -KYR-NH 2 exhibited killing activity around 80% within the first 10 min after treatment, similar to the activity of Gentamicin or polymyxin B. This suggested that all bacteria strains except K. pneumoniae ATCC 17736 were susceptible to C 12 -KYR-NH 2 and C 14 -KYR-NH 2 . C 12 -and C 14 -KYR-NH 2 at 40 μM showed 70-85% killing activity within 1.5 h in Gram-positive bacteria (S. aureus 1466 and S. epidermidis ATCC 12228, respectively, Fig. 5A-B) , and 85% in Gram-negative bacteria (E. coli O157:H7 ATCC 43895, Fig. 5C ). Both LiPs exhibited only 50% killing activity against K. pneumoniae ATCC 17736 (Fig. 5D) . The fast killing action supports the possibility of using LiPs as candidates for fastacting therapeutics.
Cell selectivity of LiPs
The hemolytic activity of LiPs against the diluted solution of human erythrocytes is shown in Fig. 6 and summarized in Table 1 . All LiPs exhibited a low hemolytic ratio (b10%) within a concentration range of 2 μM to 256 μM and. Unlike LiPs, polymyxin B caused more than 10% hemolysis at concentrations above 32 μM. This result indicated that LiPs displayed cell selectivity toward prokaryotic cells but not human erythrocytes. We further investigated the cellular cytotoxicity of the LiPs against Vero cells (monkey kidney epithelial cells), and found that all LiPs exhibited no cytotoxicity at 40 μM but strong cytotoxicity at 80 μM. Our results show a similar pattern with other studies where C 12 -OOWW-NH 2 exhibited cytotoxicity at 120 μM [9] . At higher concentrations, LiPs may interact with the zwitterionic membranes of the eukaryotic cells by entropic force rather than electrostatic interaction, inducing membrane rupture by inserting the hydrocarbon tail into the lipid bilayer. When considering the length of the hydrocarbon tail, C 12 -KYR-NH 2 exhibited the least cytotoxicity, indicating that the acyl chain length of the LiPs is one of the factors in determining their cytotoxicity.
Next, we analyzed the selectivity of LiPs towards human erythrocytes by determining the Selectivity Index (SI) of each LiP. SI is the ratio of the concentration causing 10% hemolysis (HC 10 ) to the average MIC 80 values of 4 strains tested (GM, geometric index) [41, 44] . Higher SI values indicate more selective LiPs. As shown in Fig. 7 and in Table 1 , selectivity indices (SI) of LiPs directly correlate with inhibitory activity. This phenomenon was especially marked for C 14 -KYR-NH 2 , which exhibited the highest SI (10.24), whereas the parental peptide, KYR-NH 2 , had SI 8 times lower than that of C 14 -KYR-NH 2 . The SI of C 16 -KYR-NH 2 was also low (0.8), indicating that it was inactive. Its low hemolytic activity and high antimicrobial activity suggests that C 14 -KYR-NH 2 may have potential for use in antimicrobial drug development, but with as low concentration as possible if used in order to avoid cytotoxicity to other types of host cells. It is generally known that cationic AMPs and some LiPs electrostatically interact with the acidic phospholipids found on the outer leaflet of the bacterial membrane. On the other hand, these AMPs and LiPs appeared to have much lower binding affinity to the mammalian cells, since the membrane components are composed of zwitterionic phospholipids. Therefore, AMPs and LiPs have a preferential activity or selectivity against bacteria, fungi, and even some protozoa [45, 46] . 
Chain length-dependent mode of action of LiPs
Permeabilization and depolarization studies
To investigate the membrane-permeabilization ability of LiPs, we followed the fluorescence of two probes, N-phenyl-1-naphthylamine (NPN) for outer membrane permeability and SYTOX® Green for inner membrane permeability of bacterial cells after treatment with LiPs. NPN exhibited weak fluorescence in an aqueous environment, but strong fluorescence in the hydrophobic environment of a membrane after partitioning into the disrupted outer membrane. An increase in NPN fluorescence was observed due to outer membrane disintegration by LiP permeabilization. Following outer membrane permeabilization, LiPs may penetrate deeper into the inner membrane leading to inner membrane disruption. This phenomenon can be followed by using the SYTOX® Green fluorescent dye that can penetrate into the disintegrated inner membrane to give higher fluorescence when binding to the genomic DNA inside the bacterial cells.
Our results show that C 12 -, C 14 -, and C 16 -KYR-NH 2 had the ability to disrupt the outer membrane of E. coli O157:H7 ATCC 43895 (Fig. 8A ) within 3 min, as seen by the rapid increase in NPN fluorescence up to 50% of the maximum fluorescence. After 3 min, the fluorescence intensity was stable until at least 60 min. C 10 -KYR-NH 2 and KYR-NH 2 did not exert outer membrane permeabilization in E. coli O157:H7. When analyzing the correlation between killing activity and outer membrane permeability, we found that with little outer membrane permeability in Gram negative bacteria and little cytoplasmic membrane permeability in Gram positive bacteria, C 10 -KYR-NH 2 and KYR-NH 2 also show little activity in killing the bacteria (40% and 20%, respectively). C 16 -KYR-NH 2 , in contrast, showed discrepancy of such correlation. It had effective outer membrane permeability but relatively inactive in bacterial killing. This is not very surprising to us since it has been shown that the long acyl chain in the ultrashort LiPs could lead to the formation of aggregate structures of the LiPs. These aggregates are thought to be unable to traverse across the outer membrane to further induce inner membrane disruption [8] .
Unlike quick and stable outer membrane permeabilization, LiPs exhibited a more dynamic manner for inner and cytoplasmic membrane permeabilization (Fig. 8B and C, respectively) . Within the 60-minute time frame of observation, all LiPs could induce permeabilization of the inner membrane of E. coli O157:H7 ATCC 43895 (Fig. 8B ) and cytoplasmic membrane of S. aureus 1466, respectively (Fig. 8C) . C 14 -KYR-NH 2 permeabilization was the fastest, giving highest inner membrane permeability within 3 min, as shown by strong fluorescence of SYTOX® Green. After that, the fluorescence slowly increased until reaching saturation after 20 min, indicating slow penetration of the dye through the inner membrane. C 12 -KYR-NH 2 effectively permeated the inner membrane within the first 10 min, reaching to the levels similar to C 14 -KYR-NH 2 after 20 min. C 16 -KYR-NH 2 rarely showed inner membrane permeabilization within the first 20-30 min, but it eventually reached levels equivalent to those of C 12 -KYR-NH 2 and C 14 -KYR-NH 2 after 60 min.
Our findings demonstrated some characteristics of LiPs that have never been observed before. First, there is little relationship between the outer and inner membrane permeabilization activities of each LiP. Although most LiPs permeated the outer membrane with similar rates, they showed remarkably different inner membrane permeabilization rates. Second, the killing activity of the LiPs correlated directly with inner membrane permeability, but only if permeabilization could be observed within the first 10 min of LiP treatment. Our study found that the ranking of the LiPs from highest to lowest killing activity was: C 14 -KYR-NH 2 N C 12 -KYR-NH 2 N C 10 -KYR-NH 2 N C 16 -KYR-NH 2 = KYR-NH 2 (Figs. 5 and 8C and D). Even though C 16 -KYR-NH 2 could cause similarly high levels of inner membrane permeabilization after a longer period of time (Fig. 8D) , this late permeabilization appeared not to affect the viability of the bacterial cells even after 10 min of incubation (Fig. 5) . This finding demonstrated that the fatty acid length is important for the LiP ability to traverse across the membrane. The chain length could be long enough to allow the maximum disruption, but it may not relate to the killing activity in case of C 16 -KYR-NH 2 .
Maintenance of membrane polarity is essential for bacteria to selectively balance the electrolytes between the outside and inside environments of the cell. Loss of physical integrity of the membrane due to LiP attack leads to loss of membrane polarity, and eventual uncontrollable ion balance. This phenomenon is called membrane depolarization [47] . To assess the membrane depolarization ability of the LiPs, we followed the fluorescence of the membrane-potential-sensitive dye, DiBAC 4 (3), as a function of LiP treatment in both a concentration-and time-dependent manner. An increase in the fluorescence intensity of DiBAC 4 (3) is proportional to the degree of membrane potential reduction [47] . At 40 μM, C 14 -KYR-NH 2 induced the greatest depolarization of the bacterial membrane of both E. coli O157:H7 ATCC 43895 and S. aureus 1466, while little or no depolarization was observed for KYR-NH 2 and C 16 -KYR-NH 2 ( Fig. 9A and B) . Membrane depolarization was stably saturated after 15 min treatment by all LiPs. The results demonstrate that membrane depolarization ability of LiPs was dependent on the fatty acid length and concentration, but not time. In addition, our results indicate that besides having the strongest killing activity, outer and inner membrane permeabilization ability, C 14 -KYR-NH 2 also has the strongest membrane depolarization activity, albeit its activity was not as high as that of PMB. Whereas the majority of antibacterial LiP studies focused on structure-activity relationship of LiPs and ultrashort LiPs [9, 14, 35] , our study demonstrates the relationship between the chain length and the killing activity of LiPs with a mechanistic explanation of how chain length affect the activity. In general, LiPs act via two major mechanisms: 1) inhibiting the synthesis of the compounds in the cell wall structure such as glucan or chitin, and 2) inducing membrane disintegration [48] . The acylation in LiPs modifies the overall hydrophobicity of the molecule, affecting their oligomeric states both in solution and on membrane [49] . Once interacting with the membrane, these oligomers should be capable of dissociating in order to permeate and cause membrane depolarization, to an eventual membrane disintegration [16] . Different chain length plays a pivotal role in modulating LiP activity via different extent of membrane permeability as seen in this study. We were able to correlate the chain length with three corresponding membrane disruption mechanisms: outer membrane permeability, inner membrane permeability, and membrane depolarization, in a timecourse manner. The results indicate that the optimal length of the fatty acid to allow most effective membrane disruption in this study is 12-14 carbon atom. 2 and C 14 -KYR-NH 2 on bacterial membranes observed by AFM Live cells in buffer were attached onto cover glasses under physiological conditions in order to visualize the effect of active LiPs on these cells. 20 μM of either KYR-NH 2 or C 14 -KYR-NH 2 was incubated with live E. coli HB 101 cells on the cover glass for 15 min or 30 min. Images of the cell surface were then taken, and processed to be deflection images with atomic force microscopy (Asylum Research, USA). Based on the AFM image of E. coli HB 101 shown in Fig. 10 , C 14 -KYR-NH 2 could induce a roughness on the cell surface as evidenced by the elongated, wrinkled, and severely ruptured cell morphology (Fig. 10F and J) , in contrast to the untreated cells which exhibited a normal smooth surface (Fig. 10A and B) . Treating live cells with KYR-NH 2 resulted in bacterial surfaces that were minimally damaged, giving a cellular morphology similar to that observed in untreated cells (Fig. 10D and H) . This is clearly demonstrated by our AFM results that showed that C 14 -KYR-NH 2 causes surface damage that corresponded well with the membrane permeabilization experiments mentioned earlier in this section.
Effect of KYR-NH
To summarize the mechanism of how LiPs kill the microorganisms tested, we propose the model illustrated in Fig. 11 . C 12 -and C 14 -KYR-NH 2 are first bound to the outer membrane of the bacterial cell, within 3 min they permeabilized into the outer membrane. C 12 and C 14 -KYR-NH 2 further induced inner (cytoplasmic) membrane permeability and also completely depolarized the bacterial membrane of both E. coli O157:H7 ATCC 43895 and S. aureus 1466, indicating that they severely affect the viability of the pathogen, resulting in death within 10 min. The killing ability ranked as C 14 -KYR-NH 2 N C 12 -KYR-NH 2 N C 10 -KYR-NH 2 N C 16 -KYR-NH 2 = KYR-NH 2 . It has also been noted that neither the hydrophobicity of the acyl chain nor the length of the aliphatic moiety directly correlates with the biological function of the peptides [9] . For example, the less hydrophobic LiP C 14 -KYR-NH 2 is more potent than the longest acyl chain length, C 16 -KYR-NH 2 . C 14 -KYR-NH 2 was active against Gram-positive bacteria, whereas the more hydrophobic C 16 -KYR-NH 2 is not active in any experiment.
Conclusion
Generally, modification of peptides by changing the amino acid sequence or by alternating their order within the sequence has been shown to increase antimicrobial activity. A large body of studies have been published in which AMPs are rationally designed by swapping and/or truncating amino acids in order to obtain more potent AMPs. In contrast, AMP activity improvement by modifying the peptides with other biomolecules such as carbohydrates and lipids are in their early steps. This study expands on the proof-of-concept of modifying peptides with lipids in order to yield higher antimicrobial activity compared to the parent unmodified peptides. Lipid modification of AMPs can improve their antimicrobial activity, increase their in vivo efficacy and retention, and lower the cost of their manufacture. By adding an acyl chain to modify the ultrashort peptide, our study demonstrates the potent antibacterial activity of the modified LiPs. Addition of an acyl chain of 12-14 carbon atoms in length gave the highest antibacterial activity, indicating that hydrophobicity is a key parameter dictating the biological activity of this peptide. Importantly, our study also demonstrates that the aliphatic peptide part and hydrophobic lipid part of the LiPs had to work together to allow membrane destabilization, depolarization, and eventual disintegration -all of which are similar to the primary steps in the killing mechanism of a typical AMP.
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